JP2018512874A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018512874A5 JP2018512874A5 JP2017555218A JP2017555218A JP2018512874A5 JP 2018512874 A5 JP2018512874 A5 JP 2018512874A5 JP 2017555218 A JP2017555218 A JP 2017555218A JP 2017555218 A JP2017555218 A JP 2017555218A JP 2018512874 A5 JP2018512874 A5 JP 2018512874A5
- Authority
- JP
- Japan
- Prior art keywords
- expression vector
- pharmaceutical composition
- mammal
- kdm4d
- hyperplasia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021045410A JP7325466B2 (ja) | 2015-04-20 | 2021-03-19 | 再生医療のためのベクターおよび方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562150159P | 2015-04-20 | 2015-04-20 | |
| US62/150,159 | 2015-04-20 | ||
| PCT/US2016/028459 WO2016172224A1 (en) | 2015-04-20 | 2016-04-20 | Vectors and methods for regenerative therapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021045410A Division JP7325466B2 (ja) | 2015-04-20 | 2021-03-19 | 再生医療のためのベクターおよび方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018512874A JP2018512874A (ja) | 2018-05-24 |
| JP2018512874A5 true JP2018512874A5 (https=) | 2019-05-23 |
| JP6910305B2 JP6910305B2 (ja) | 2021-07-28 |
Family
ID=57143414
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017555218A Expired - Fee Related JP6910305B2 (ja) | 2015-04-20 | 2016-04-20 | 再生医療のためのベクターおよび方法 |
| JP2021045410A Active JP7325466B2 (ja) | 2015-04-20 | 2021-03-19 | 再生医療のためのベクターおよび方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021045410A Active JP7325466B2 (ja) | 2015-04-20 | 2021-03-19 | 再生医療のためのベクターおよび方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11331377B2 (https=) |
| EP (2) | EP3936188B1 (https=) |
| JP (2) | JP6910305B2 (https=) |
| AU (2) | AU2016252619B2 (https=) |
| CA (1) | CA2981811A1 (https=) |
| DK (1) | DK3285871T3 (https=) |
| ES (1) | ES2894673T3 (https=) |
| HU (1) | HUE055902T2 (https=) |
| PL (1) | PL3285871T3 (https=) |
| PT (1) | PT3285871T (https=) |
| WO (1) | WO2016172224A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109504710B (zh) * | 2018-12-04 | 2021-03-26 | 首都医科大学附属北京口腔医院 | Kdm4d的用途 |
| WO2023056456A1 (en) * | 2021-10-01 | 2023-04-06 | University Of Washington | Vectors and methods for improving cardiac regeneration |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090275099A1 (en) | 2004-04-27 | 2009-11-05 | Regents Of The University Of Michigan | Methods and compositions for treating diseases and conditions associated with mitochondrial function |
| AU2008333972A1 (en) | 2007-11-30 | 2009-06-11 | New York Medical College | Compositions comprising HDAC inhibitors and methods of their use in restoring stem cell function and preventing heart failure |
| WO2013155330A1 (en) * | 2012-04-11 | 2013-10-17 | University Of Massachusetts | Compositions and methods for characterizing and treating muscular dystrophy |
| WO2014014518A1 (en) * | 2012-07-18 | 2014-01-23 | Dana-Farber Cancer Institute, Inc. | Methods for treating, preventing and predicting risk of developing breast cancer |
| WO2014085613A1 (en) * | 2012-11-30 | 2014-06-05 | Mccord Darlene E | Hydroxytyrosol and oleuropein compositions for induction of dna damage, cell death and lsd1 inhibition |
| WO2015048577A2 (en) | 2013-09-27 | 2015-04-02 | Editas Medicine, Inc. | Crispr-related methods and compositions |
-
2016
- 2016-04-20 EP EP21186914.4A patent/EP3936188B1/en active Active
- 2016-04-20 CA CA2981811A patent/CA2981811A1/en active Pending
- 2016-04-20 ES ES16783775T patent/ES2894673T3/es active Active
- 2016-04-20 WO PCT/US2016/028459 patent/WO2016172224A1/en not_active Ceased
- 2016-04-20 US US15/566,987 patent/US11331377B2/en active Active
- 2016-04-20 AU AU2016252619A patent/AU2016252619B2/en not_active Ceased
- 2016-04-20 PL PL16783775T patent/PL3285871T3/pl unknown
- 2016-04-20 PT PT167837756T patent/PT3285871T/pt unknown
- 2016-04-20 DK DK16783775.6T patent/DK3285871T3/da active
- 2016-04-20 HU HUE16783775A patent/HUE055902T2/hu unknown
- 2016-04-20 JP JP2017555218A patent/JP6910305B2/ja not_active Expired - Fee Related
- 2016-04-20 EP EP16783775.6A patent/EP3285871B1/en active Active
-
2021
- 2021-03-19 JP JP2021045410A patent/JP7325466B2/ja active Active
- 2021-09-20 AU AU2021232850A patent/AU2021232850A1/en not_active Abandoned
-
2022
- 2022-04-18 US US17/659,598 patent/US20220249623A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lyu et al. | Macrophage-mediated regulation of catecholamines in sympathetic neural remodeling after myocardial infarction | |
| JP7693290B2 (ja) | Ｌａｒファミリーホスファターゼの活性を阻害する組成物及び方法 | |
| Sémont et al. | Mesenchymal stem cells increase self-renewal of small intestinal epithelium and accelerate structural recovery after radiation injury | |
| RU2014137169A (ru) | Системная доставка и регулируемая экспрессия паракринных генов для лечения сердечно-сосудистых и иных заболеваний | |
| Huang et al. | Time‐restricted release of multiple neurotrophic factors promotes axonal regeneration and functional recovery after peripheral nerve injury | |
| JP2016521708A5 (https=) | ||
| JP2014227368A (ja) | 糖尿病および高血糖状態の処置のためのグルカゴンアナログ | |
| JP2014506787A5 (https=) | ||
| Dougherty et al. | Taltirelin alleviates fatigue-like behavior in mouse models of cancer-related fatigue | |
| JP2018512874A5 (https=) | ||
| Daneshi et al. | Cell-free treatments: a new generation of targeted therapies for treatment of ischemic heart diseases | |
| Wu et al. | Current perspectives on imaging cardiac stem cell therapy | |
| RS64553B1 (sr) | Vektori za lečenje fridrajhove ataksije | |
| Pesce et al. | Endothelial and cardiac progenitors: boosting, conditioning and (re) programming for cardiovascular repair | |
| JP2020518644A (ja) | 虚血組織を治療するための方法 | |
| JP2017514875A (ja) | 失禁および他の括約筋不全障害を処置する方法 | |
| Altamirano et al. | Engineering the immune and fibrotic response in VML | |
| ES2743426T3 (es) | Proteína para inducir el crecimiento de vasos sanguíneos y usos de esta | |
| Alon et al. | Molecular imaging of CXCL12 promoter-driven HSV1-TK reporter gene expression | |
| Thierry et al. | Cell therapy for the treatment of accidental radiation overexposure | |
| Xiao et al. | Biological approaches to generating cardiac biopacemaker for bradycardia | |
| CN110141682A (zh) | 一种负载外源干细胞的注射型胶原材料及其在心肌损伤修复中的应用 | |
| Tang et al. | Saikosaponin A ameliorates inflammatory response by modulating P38MAPK pathway in rats with depression and myocardial ischemia | |
| Das et al. | Biological Pacemaker | |
| ES2377381A1 (es) | Uso de una combinación de n-acetil-cisteína y ácido lipoico para la preparación de un medicamento útil para el tratamiento de una enfermedad con daño axonal y lesiones oxidativas concomitantes. |